Vuong Trieu, CHAIRMAN AND CEO, 10% Owner at Oncotelic Therapeutics, Inc. (OTLC), bought 255,000 shares at $0.04 ($11K) on 2026-06-24, disclosed to the SEC on 2026-06-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.04 | 65,000 | $3K | 25.5% |
| 2 | $0.04 | 75,000 | $3K | 29.4% |
| 3 | $0.04 | 115,000 | $5K | 45.1% |
| Total | $0.04 avg | 255,000 | $11K | 100% |
| Filing → |
| OTLC | BUY | 2025-07-10 | $2K | — | Filing → |
| OTLC | BUY | 2025-01-31 | $10K | — | Filing → |
| OTLC | BUY | 2024-11-26 | $9K | — | Filing → |